ET, PV, and PMF were recorded more frequently in patients with JAK2 mutation, whereas reactive causes (inflammation, DEA, splenectomy) were recorded predominantly in cases without JAK2 mutation. The gene discussed is JAK2; the disease is acquired polycythemia vera.